Home News & Events Events Workshops Workshops Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Workshop Beginners/Intermediate Online NONMEM/PDx-Pop Workshop Date 19 May 2026 - 20 May 2026 Time 08:00 - 18:00 Location Online/Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop Workshop Date 21 May 2026 Time 09:00 - 17:00 Location Online/Webex Timezone America/New York Workshop New and Advanced Features of NONMEM 7.6 Workshop Date 1 June 2026 Time 09:00 - 17:00 Location Dubrovnik, Croatia Timezone Europe/Bratislava In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Webpage Webinars Webpage Industry Events What’s happening in ICON ICON Plc ICON is proud to be recognised among the top global companies in the world for female employees. As of 31 December 2024, women make up 70% of our workforce and hold 60% of director-level and above roles—a powerful refle... 8 Mar View post View webpage ICON Plc Join Steve Hunt at Medidata NEXT New York for a roundtable discussion on real world lessons from early adopters of Medidata Designer. Steve will share what effective adoption looks like in practice, where ICON teams are ... 6 Mar View post View webpage ICON Plc The oncology R&D landscape is rapidly evolving, driven by multi‑modality therapeutics, precision‑designed studies, and the growing measurable impact of AI on discovery and development. These shifts are reshaping how spon... 6 Mar View post View webpage ICON Plc Last week, our teams across ICON came together to recognise Rare Disease Day and raise awareness for the millions of people and families living with rare conditions. Colleagues took part in activities including creating... 6 Mar View post ICON Plc Why are clinical trial start-up timelines getting longer despite digital innovation? ICON’s industry survey of 100+ sites and commentary from Brian Mallon, EVP Site & Patient Solutions, uncover the complexity, contract... 6 Mar View post View webpage ICON Plc Vaccine guidance for patients with rare autoimmune diseases can be challenging, given the low prevalence of some of these conditions and limited understanding of the impacts of vaccines in these patients. Discover how va... 5 Mar View post View webpage ICON Plc Rare autoimmune diseases can leave patients particularly vulnerable to infection, but they often require unique considerations for vaccination. Learn what makes these cases so unique, and what to take into account when b... 5 Mar 1 View post View webpage ICON Plc China’s life‑sciences sector continues to advance rapidly, creating new opportunities for more efficient and globally competitive clinical development. In ICON’s latest blog, Yao Zhong outlines the key factors enabling i... 5 Mar View post View webpage ICON Plc Join ICON at #OCT Southeast on 10 March at 9:30am EST as Shelley McLendon, Senior Vice President, Program Management, shares a CRO perspective on the global biotech sector. She will discuss the landscape shaping biotec... 5 Mar View post View webpage ICON Plc Human ADME studies are essential for understanding how investigational drugs are absorbed, distributed, metabolised and excreted. Yet traditional sampling—limited to plasma, urine and faeces- leaves a key blind spot: bil... 5 Mar View post View webpage ICON Plc Non-invasive testing could transform the management of metabolic liver disease and help shape the future of MASH clinical development. This article in SelectScience® Science explores the evolving NIT landscape, emerging... 5 Mar View post View webpage ICON Plc On 15 April at 12:00 pm, join ICON’s Alan Baldridge at the GLP‑1‑Based Therapeutics Summit for his session, “Is there anything GLP‑1s can’t do? Unlocking the next generation of metabolic treatments.” He will offer a fo... 4 Mar View post View webpage
